Article
Functional and molecular characterization of PD1+ tumor-infiltrating lymphocytes from lung cancer patients.
2022-01-01
Abstract excerpt
Antibody-mediated cancer immunotherapy targets inhibitory surface molecules, such as PD1, PD-L1, and CTLA-4, aiming to re-invigorate dysfunctional T cells. We purified and characterized tumor-infiltrating lymphocytes (TILs) and their patient-matched non-tumor counterparts from treatment-naïve NSCLC patient biopsies to evaluate the effect of PD1 expression on the functional and molecular profiles of tumor-resident...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 91011f5d-ea93-5654-8c09-2f236c66b7ed
- DOI
- 10.48350/165815
